Bioadaptives, Inc. (BDPT): Total Assets
$225.9K
As of 2025-12-31
$78.8K
As of 2026-06-30
+82.3%
3-year compound annual growth
+64.3%
5-year compound annual growth
+41.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $225.9K | -13.7% | 2026-04-14, Balance as of period end |
| 2024-12-31 | $261.9K | +151.8% | 2026-04-14, Balance as of period end |
| 2023-12-31 | $104.0K | +178.7% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $37.3K | -74.9% | 2024-04-10, Balance as of period end |
| 2021-12-31 | $148.6K | +688.4% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $18.8K | -22.2% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $24.2K | -78.0% | 2021-03-30, Balance as of period end |
| 2018-12-31 | $110.1K | n/a | 2020-05-12, Balance as of period end |
| No annual figure between 2015-12-31 and 2018-12-31. | |||
| 2015-12-31 | $7.2K | -89.8% | 2016-04-14, Balance as of period end |
| 2014-12-31 | $70.8K | -41.2% | 2016-04-14, Balance as of period end |
| 2013-12-31 | $120.3K | n/a | 2015-04-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $29.72M | +63.0% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $17.41M | -14.2% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
Compare BDPT, PRFX, SKVI, JUNS side by side · Screen every company in Pharmaceutical Preparations ↗